Phenotyping Patients Admitted with Asthma Exacerbations: Can We Identify At-Risk Patients?

被引:0
|
作者
Ananth, S. [1 ]
Vancheeswaran, R. [1 ]
机构
[1] West Hertfordshire Hosp NHS Trust, Dept Resp Med, London, England
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1425
引用
收藏
页数:3
相关论文
共 50 条
  • [21] How can we identify patients with asthma-COPD overlap syndrome in clinical practice?
    Barrecheguren, Miriam
    Esquinas, Cristina
    Miravitlles, Marc
    ARCHIVOS DE BRONCONEUMOLOGIA, 2016, 52 (02): : 59 - +
  • [22] CTAG CAN IDENTIFY AT-RISK NASH PATIENTS IN A NAFLD POPULATION: COMPOSITE BIOMARKER VALIDATION STUDY
    Kazimianec, Arina
    Dennis, Andrea
    Kelly, Matt
    Banerjee, Rajarshi
    Imajo, Kento
    Nakajima, Atsushi
    Harrison, Stephen A.
    HEPATOLOGY, 2021, 74 : 947A - 947A
  • [23] EXACERBATIONS OF ASTHMA IN PATIENTS ON SALMETEROL
    JENKINS, MM
    HILTON, CJ
    DEKOCK, JC
    PALMER, JBD
    LANCET, 1991, 337 (8746): : 913 - 914
  • [24] Exacerbations in patients with severe asthma
    Garcia De la Fuente, A.
    Albendiz Gutierrez, V. J.
    De Castro Martinez, F. J.
    Zubeldia Ortuno, J. M.
    ALLERGY, 2019, 74 : 723 - 724
  • [25] Violent behaviour in early psychosis patients: Can we identify clinical risk profiles?
    Moulin, Valerie
    Palix, Julie
    Golay, Philippe
    Dumais, Alexandre
    Gholamrezaee, Mohammad Mehdi
    Azzola, Agathe
    Baunnann, Philipp S.
    Alanneda, Luis
    Conus, Philippe
    EARLY INTERVENTION IN PSYCHIATRY, 2019, 13 (03) : 517 - 524
  • [26] Can we identify patients at risk of life-threatening allergic reactions to food?
    Turner, P. J.
    Baumert, J. L.
    Beyer, K.
    Boyle, R. J.
    Chan, C. -H.
    Clark, A. T.
    Crevel, R. W. R.
    DunnGalvin, A.
    Fernandez-Rivas, M.
    Gowland, M. H.
    Grabenhenrich, L.
    Hardy, S.
    Houben, G. F.
    Hourihane, J. O'B
    Muraro, A.
    Poulsen, L. K.
    Pyrz, K.
    Remington, B. C.
    Schnadt, S.
    van Ree, R.
    Venter, C.
    Worm, M.
    Mills, E. N. C.
    Roberts, G.
    Ballmer-Weber, B. K.
    ALLERGY, 2016, 71 (09) : 1241 - 1255
  • [27] Dead is dead, but can we identify patients at increased risk for sudden cardiac death?
    Moss, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) : 659 - 660
  • [28] Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma?
    Liccardi, Gennaro
    Calzetta, Luigino
    Salzillo, Antonello
    Apicella, Gerardo
    Croce, Giovanni
    Rogliani, Paola
    ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (03) : E19 - E20
  • [29] Using Predictive Analytics to Identify Risk of Clinical Asthma Exacerbations
    Granovsky, Lena
    Kamienchick, Ron
    Yacovzada, Nancy
    Viswanathan, Premprakaash
    Cao, Shuai
    Alevras, Dimitris
    Tamir, Ronen
    Grossman, Iris
    Ferro, Thomas
    Chary, Dilip
    Safioti, Guilherme
    Fine, Shai
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB222 - AB222
  • [30] The risk factors that identify with airflow obstruction and exacerbations in severe asthma
    Desai, D.
    Shah, S.
    Gupta, S.
    Bafadhel, M.
    Singapuri, A.
    Haldar, P.
    Monteiro, W.
    Pavord, I. D.
    Wardlaw, A.
    Brightling, C. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181